Explore Charles River QC Solutions

PALLCHEK™ Meets FDA Approval for Evaluation of Microbial Contamination in Pharmaceuticals


For the first time the FDA have approved the use of ATP bioluminescence for the evaluation of microbial contamination in the pharmaceutical industry.

PALLCHEK™ is the first Rapid Microbiology System, based on ATP bioluminescence, that has successfully and completely met the necessary requirements needed for getting the FDA approval under Process Analytical Technologies (PAT) initiative, as a test method for pharmaceutical product release.

Routine usage of the PALLCHEK Rapid Microbiology System requires only a modest financial investment. It is easy to validate, offering a rapid return of the economical investment.

Visit the Pall Website at pall.com to find out more about the GeneDiscĀ® Rapid Microbiology System.

NOTE: This item is from our 'historic' database and may contain information which is not up to date.

Source : Pall Life Sciences - Laboratory Products View Company Information

Posted on April 14, 2005